These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 34997148)

  • 1. Synergism of imipenem with fosfomycin associated with the active cell wall recycling and heteroresistance in Acinetobacter calcoaceticus-baumannii complex.
    Singkham-In U; Chatsuwan T
    Sci Rep; 2022 Jan; 12(1):230. PubMed ID: 34997148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activities of carbapenems in combination with amikacin, colistin, or fosfomycin against carbapenem-resistant Acinetobacter baumannii clinical isolates.
    Singkham-In U; Chatsuwan T
    Diagn Microbiol Infect Dis; 2018 Jun; 91(2):169-174. PubMed ID: 29433997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OXA-Carbapenemases Present in Clinical Acinetobacter baumannii-calcoaceticus Complex Isolates from Patients in Kurdistan Region, Iraq.
    Ganjo AR; Maghdid DM; Mansoor IY; Kok DJ; Severin JA; Verbrugh HA; Kreft D; Fatah MH; Alnakshabandi AA; Dlnya A; Hammerum AM; Ng K; Goessens W
    Microb Drug Resist; 2016 Dec; 22(8):627-637. PubMed ID: 27003287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial resistance determinants in imipenem-nonsusceptible Acinetobacter calcoaceticus-baumannii complex isolated in Daejeon, Korea.
    Sung JY; Kwon KC; Cho HH; Koo SH
    Korean J Lab Med; 2011 Oct; 31(4):265-70. PubMed ID: 22016680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RT-PCR and statistical analyses of adeABC expression in clinical isolates of Acinetobacter calcoaceticus-Acinetobacter baumannii complex.
    Ruzin A; Immermann FW; Bradford PA
    Microb Drug Resist; 2010 Jun; 16(2):87-9. PubMed ID: 20438348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Typing and characterization of carbapenem-resistant Acinetobacter calcoaceticus-baumannii complex in a Chinese hospital.
    Yu YS; Yang Q; Xu XW; Kong HS; Xu GY; Zhong BY
    J Med Microbiol; 2004 Jul; 53(Pt 7):653-656. PubMed ID: 15184537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro synergistic activity of sulbactam in combination with imipenem, meropenem and cefoperazone against carbapenem-resistant Acinetobacter baumannii isolates].
    Turk Dagi H; Kus H; Arslan U; Tuncer I
    Mikrobiyol Bul; 2014 Apr; 48(2):311-5. PubMed ID: 24819268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of colistin or sulbactam in combination with fosfomycin or imipenem against clinical isolates of carbapenem-resistant Acinetobacter baumannii producing OXA-23 carbapenemases.
    Santimaleeworagun W; Wongpoowarak P; Chayakul P; Pattharachayakul S; Tansakul P; Garey KW
    Southeast Asian J Trop Med Public Health; 2011 Jul; 42(4):890-900. PubMed ID: 22299471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbapenem susceptibility testing errors using three automated systems, disk diffusion, Etest, and broth microdilution and carbapenem resistance genes in isolates of Acinetobacter baumannii-calcoaceticus complex.
    Markelz AE; Mende K; Murray CK; Yu X; Zera WC; Hospenthal DR; Beckius ML; Calvano T; Akers KS
    Antimicrob Agents Chemother; 2011 Oct; 55(10):4707-11. PubMed ID: 21807971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptidoglycan recycling contributes to intrinsic resistance to fosfomycin in Acinetobacter baumannii.
    Gil-Marqués ML; Moreno-Martínez P; Costas C; Pachón J; Blázquez J; McConnell MJ
    J Antimicrob Chemother; 2018 Nov; 73(11):2960-2968. PubMed ID: 30124902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence and antibiotic resistance profiles of clinical Acinetobacter calcoaceticus-Acinetobacter baumannii (ACB) and non-ACB complex members in companion animals: A 2020-2022 retrospective study.
    Attili AR; Nocera FP; Sisto M; Linardi M; Gigli F; Ngwa VN; Fiorito F; Cerracchio C; Meligrana MCT; Bonacucina E; Cuteri V; De Martino L
    Comp Immunol Microbiol Infect Dis; 2024 Jun; 109():102185. PubMed ID: 38663213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of ACB complex genospecies on clinical outcomes in a U.S. hospital with high rates of multidrug resistance.
    Fitzpatrick MA; Ozer E; Bolon MK; Hauser AR
    J Infect; 2015 Feb; 70(2):144-52. PubMed ID: 25246361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcomes of hospital-acquired infection with Acinetobacter nosocomialis and Acinetobacter pittii.
    Chusri S; Chongsuvivatwong V; Rivera JI; Silpapojakul K; Singkhamanan K; McNeil E; Doi Y
    Antimicrob Agents Chemother; 2014 Jul; 58(7):4172-9. PubMed ID: 24820079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variations of CHROMagar Acinetobacter to detect imipenem-resistant Acinetobacter baumannii-calcoaceticus complex.
    Barsoumian A; Calvano T; Markelz AE; Cassidy R; Murray CK; Beckius ML; Mende K; Akers KS
    Scand J Infect Dis; 2013 Jun; 45(6):446-52. PubMed ID: 23317168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel approach to optimize synergistic carbapenem-aminoglycoside combinations against carbapenem-resistant Acinetobacter baumannii.
    Yadav R; Landersdorfer CB; Nation RL; Boyce JD; Bulitta JB
    Antimicrob Agents Chemother; 2015 Apr; 59(4):2286-98. PubMed ID: 25645842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oligonucleotide array-based identification of species in the Acinetobacter calcoaceticus-A. baumannii complex in isolates from blood cultures and antimicrobial susceptibility testing of the isolates.
    Ko WC; Lee NY; Su SC; Dijkshoorn L; Vaneechoutte M; Wang LR; Yan JJ; Chang TC
    J Clin Microbiol; 2008 Jun; 46(6):2052-9. PubMed ID: 18385442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outbreak of imipenem-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex harboring different carbapenemase gene-associated genetic structures in an intensive care unit.
    Lee YT; Fung CP; Wang FD; Chen CP; Chen TL; Cho WL
    J Microbiol Immunol Infect; 2012 Feb; 45(1):43-51. PubMed ID: 22169123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of clinical manifestations and antibiotic resistances among three genospecies of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex.
    Chen L; Yuan J; Xu Y; Zhang F; Chen Z
    PLoS One; 2018; 13(2):e0191748. PubMed ID: 29389980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endemic carbapenem-nonsusceptible
    Saharman YR; Karuniawati A; Sedono R; Aditianingsih D; Sudarmono P; Goessens WHF; Klaassen CHW; Verbrugh HA; Severin JA
    Antimicrob Resist Infect Control; 2018; 7():5. PubMed ID: 29344351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular typing of imipenem-resistant Acinetobacter baumannii-calcoaceticus complex in a Singapore hospital where carbapenem resistance is endemic.
    Tan TY; Poh K; Ng SY
    Infect Control Hosp Epidemiol; 2007 Aug; 28(8):941-4. PubMed ID: 17620241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.